Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Morphine dependency in mice blocked by the kappa-opioid receptor agonist TRK-820

May 30, 2000

Yale receives NIDA grant to advance Cantab's anticocaine vaccine

May 19, 2000

Zyban approved in E.U. for smoking cessation

May 4, 2000

NIDA recommends Nabi-NicVAX funding for treatment and prevention of nicotine dependence

April 13, 2000

Antagonists of alcohol's harmful effects in nerve cells discovered

March 30, 2000

Clinical trial results show DigiTAb to be safe and effective for oleander poisoning

March 28, 2000

Ferriprox launched in Europe

March 22, 2000

Nabi and the NIDA begin toxicity studies of Nabi-NicVAX

March 9, 2000

Nabi-NicVAX attenuates nicotine dependence in rats

March 1, 2000

Study disproves earlier reports of serious treatment-related side effect of deferiprone

Feb. 24, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...